Kathleen A. Rickard Verona Pharma PLC (VRNA) insider trading activity
Kathleen A. Rickard is Chief Medical Officer of Verona Pharma plc. Currently has a direct ownership of 2.91 Million shares of VRNA, which is worth approximately $113 Million. The most recent transaction as insider was on Sep 26, 2022, when has been sold 800,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.91M
10.81%
3M change
2.49%
12M change
Total Value Held
$113 Million
Kathleen A. Rickard Transaction History
KAR
Kathleen A. Rickard
Chief Medical Officer
London, X0